{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["2023"],"submitter":["Zhao M"],"pubmed_abstract":["<h4>Objective</h4>This nationwide, multicenter prospective observational study with a patient registry was designed to evaluate the efficacy of Fufang E'jiao Jiang (FEJ) in Chinese patients with Qi and blood deficiency syndrome (QBDS).<h4>Methods</h4>QBDS patients were consecutively recruited from 81 investigational sites in China from July, 2019, to December, 2020. Patients who met the eligibility criteria were enrolled in a prospective registry database. Baseline characteristics and changes in scores on the traditional Chinese medicine (TCM) symptom evaluation scale for Qi and blood deficiency, the clinical global impression (CGI) scale, the fatigue scale-14 (FS-14), and the Pittsburgh sleep quality index (PSQI) were analyzed to determine the clinical efficacy of FEJ.<h4>Results</h4>A to"],"journal":["Evidence-based complementary and alternative medicine : eCAM"],"pagination":["3179489"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9918352"],"repository":["biostudies-literature"],"pubmed_title":["Efficacy of Fufang E'jiao Jiang in the Treatment of Patients with Qi and Blood Deficiency Syndrome: A Real-World Prospective Multicenter Study with a Patient Registry."],"pmcid":["PMC9918352"],"pubmed_authors":["Li G","Zhao M","Xiao M","Shi S","Ying J","Qiu P","Zhang L","Lu F","Chen S","Zhao Y","Wu H","Tan Q"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy of Fufang E'jiao Jiang in the Treatment of Patients with Qi and Blood Deficiency Syndrome: A Real-World Prospective Multicenter Study with a Patient Registry.","description":"<h4>Objective</h4>This nationwide, multicenter prospective observational study with a patient registry was designed to evaluate the efficacy of Fufang E'jiao Jiang (FEJ) in Chinese patients with Qi and blood deficiency syndrome (QBDS).<h4>Methods</h4>QBDS patients were consecutively recruited from 81 investigational sites in China from July, 2019, to December, 2020. Patients who met the eligibility criteria were enrolled in a prospective registry database. Baseline characteristics and changes in scores on the traditional Chinese medicine (TCM) symptom evaluation scale for Qi and blood deficiency, the clinical global impression (CGI) scale, the fatigue scale-14 (FS-14), and the Pittsburgh sleep quality index (PSQI) were analyzed to determine the clinical efficacy of FEJ.<h4>Results</h4>A to","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023","modification":"2025-05-29T22:24:10.27Z","creation":"2025-05-29T22:24:10.27Z"},"accession":"S-EPMC9918352","cross_references":{"pubmed":["36777626"],"doi":["10.1155/2023/3179489"]}}